Akèy › Kansè nan tete › Arizona › Gilbert
Etid klinik pou Kansè nan tete nan Gilbert, AZ
9 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Gilbert (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Ap rekriteFaz 1
- Research Site, Gilbert
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Ap rekriteFaz 3
- Banner MD Anderson Cancer Center ( Site 0066), Gilbert
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Ap rekriteFaz 3
- Banner MD Anderson Cancer Center-Oncology ( Site 0004), Gilbert
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Ap rekriteFaz 3
- Ironwood Cancer & Research Centers, Gilbert
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Ap rekriteFaz 3
- Banner Health MD Anderson AZ, Gilbert
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Ap rekriteFaz 3
- Banner MD Anderson Cancer Center, Gilbert
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Ap rekriteFaz 3
- Banner MD Anderson Cancer Center, Gilbert
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Ap rekriteFaz 3
- Ironwood Cancer & Research Centers, Gilbert
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
Ap rekriteEtid obsèvasyon
- Banner - MD Anderson Cancer Center, Gilbert
Etid Kansè nan tete nan lòt vil
- New York City, NY134 etid
- Houston, TX126 etid
- Boston, MA111 etid
- Nashville, TN80 etid
- Los Angeles, CA72 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Durham, NC63 etid
- Queens, NY63 etid
- Chicago, IL58 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Gilbert
- Kansè Poumon ki pa ti selil12 etid
- Kansè kolorektal9 etid
- Kansè poumon8 etid
- Kansè (tout kalite)8 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
- Kansè Metastatik6 etid
- Myelom Miltip6 etid
- Ensifizyans kadyak6 etid
- Maladi kadyovaskilè6 etid
- Kansè vejik6 etid
- Limfòm Non-Hodgkin5 etid
- Limfom Difize Gwo Selil B5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.